Lidoject-2
Lidoject-2 Brand names, Lidoject-2 Analogs
- Astracaine 4%
- Astracaine 4% Forte
- Carbocaine
- Carbocaine with Neo-Cobefrin
- Chirocaine
- Chlor-Procaine
- Chloroprocain
- Chloroprocaine Hcl
- Chloroprocainum [Inn-Latin]
- Chlorprocaine
- Chlorprocainum
- Citanest Forte
- Citanest Plain
- Cloroprocaina [Inn-Spanish]
- Dalcaine
- Dilocaine
- Duranest
- Duranest-Mpf
- Halestyn
- Isocaine
- Isocaine 2%
- Isocaine 3%
- L-Caine
- Lidoject-1
- Lidoject-2
- Marcaine
- Marcaine Spinal
- Nesacaine
- Nesacaine-Ce
- Nesacaine-Mpf
- Novocain
- Octocaine
- Octocaine-100
- Octocaine-50
- Piocaine
- Polocaine
- Polocaine-Mpf
- Pontocaine
- Sensorcaine
- Sensorcaine Forte
- Sensorcaine-Mpf
- Sensorcaine-Mpf Spinal
- Septocaine
- Ultracaine D-S
- Ultracaine D-S Forte
- Xylocaine
- Xylocaine 5% Spinal
- Xylocaine Test Dose
- Xylocaine-Mpf
- Xylocaine-Mpf with Glucose
Lidoject-2 Brand Names Mixture
- No information avaliable
Lidoject-2 Chemical_Formula
C13H19ClN2O2
Lidoject-2 RX_link
http://www.rxlist.com/cgi/generic3/chloroprocaine.htm
Lidoject-2 fda sheet
Lidoject-2 msds (material safety sheet)
Lidoject-2 Synthesis Reference
No information avaliable
Lidoject-2 Molecular Weight
270.755 g/mol
Lidoject-2 Melting Point
No information avaliable
Lidoject-2 H2O Solubility
665 mg/L
Lidoject-2 State
Solid
Lidoject-2 LogP
2.464
Lidoject-2 Dosage Forms
Liquid
Lidoject-2 Indication
For the production of local anesthesia by infiltration and peripheral nerve block. They are not to be used for lumbar or caudal epidural anesthesia.
Lidoject-2 Pharmacology
Chloroprocaine is an anesthetic agent indicated for production of local or regional anesthesia, particularly for oral surgery. Chloroprocaine (like cocaine) has the advantage of constricting blood vessels which reduces bleeding, unlike other local anesthetics like lidocaine. Chloroprocaine is an ester anesthetic.
Lidoject-2 Absorption
No information avaliable
Lidoject-2 side effects and Toxicity
No information avaliable
Lidoject-2 Patient Information
When appropriate, patients should be informed in advance that they may experience temporary loss of sensation and motor activity, usually in the lower half of the body, following proper administration of epidural anesthesia.
Lidoject-2 Organisms Affected
Humans and other mammals
